Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Clausen currently holds 770,054 shares of Nuo Therapeutics, Inc. (AURX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Clausen has been a net neutral trader of AURX stock. They have purchased $0 and sold $0 worth of shares.
Peter Clausen's most recent insider trade was on Jul 31, 2025, when they sold 183,853 shares at $0.40 per share.
Peter Clausen serves as Executive at Nuo Therapeutics, Inc. (AURX). They have executed 7 insider transactions totaling $0 over their tenure at the company.
Peter Clausen holds the position of Executive at Nuo Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Peter Clausen has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Clausen was on Jul 31, 2025, when they sold $73.5K worth of AURX shares. This transaction involved 183,853 shares at $0.40 per share.
Peter Clausen currently owns 770,054 shares of Nuo Therapeutics, Inc. (AURX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Clausen's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Clausen has 7 Form 4 filings on record as an insider at Nuo Therapeutics, Inc..
Set alerts for Peter Clausen and 40,000+ other insiders.